This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Lannett Company
LCI
0,58 €
Share price
0.00%
Change (1 day)
-72.61%
Change (1 year)
Categories
Lannett Company (LCI) - Total assets
Total assets on the balance sheet as of March 2023 : €0.28 Billion
According to Lannett Company's latest financial reports the company's total assets are €0.28 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Lannett Company - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-06-30 | €0.46 B | -19.82% |
| 2021-06-30 | €0.57 B | -42.99% |
| 2020-06-30 | €1.01 B | -3.18% |
| 2019-06-30 | €1.04 B | -22.38% |
| 2018-06-30 | €1.34 B | -4.2% |
| 2017-06-30 | €1.40 B | -11.54% |
| 2016-06-30 | €1.58 B | 247.63% |
| 2015-06-30 | €0.45 B | 82.53% |
| 2014-06-30 | €0.25 B | 94.19% |
| 2013-06-30 | €0.12 B | 3.13% |
| 2012-06-30 | €0.12 B | 22.64% |
| 2011-06-30 | €0.10 B | -8.93% |
| 2010-06-30 | €0.11 B | 27.02% |
| 2009-06-30 | €88.09 M | 18.72% |
| 2008-06-30 | €74.2 M | -4.7% |
| 2007-06-30 | €77.86 M | -6.95% |
| 2006-06-30 | €83.67 M | 5.23% |
| 2005-06-30 | €79.52 M | -21.38% |
| 2004-06-30 | €0.10 B | 298.09% |
| 2003-06-30 | €25.4 M | 50.9% |
| 2002-06-30 | €16.83 M | -8.68% |
| 2001-06-30 | €18.43 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | €176.32 B | 62,067.69% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €164.15 B | 57,777.20% | 🇺🇸 USA |
 Abbott Laboratories ABT | €69.03 B | 24,240.15% | 🇺🇸 USA |
 Novartis NVS | €84.70 B | 29,766.66% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | €66.48 B | 23,340.13% | 🇬🇧 UK |